News Release

Allergy molecule identified

Peer-Reviewed Publication

Norwich BioScience Institutes

A vital molecule for resistance to food allergy has been identified and offers a potential target for therapy.

There is currently no way to treat food allergy and the only way for sufferers to manage the problem is to avoid certain foods and make sure they have injectable adrenaline at hand.

Scientists led by Dr Claudio Nicoletti at the Institute of Food Research in Norwich have found that a molecule called Interleukin-12 (IL-12) is absent during allergic responses. Dr Nicoletti suggests that by delivering an allergen in the presence of IL-12, allergic reactions could be brought back under control.

“A food protein can be perfectly harmless to one person and lethal to another, said Dr Nicoletti. “We have identified the missing molecule that normally keeps immune responses under control and appropriate.”

Having a food allergy means that the immune system responds to a food protein as if it was harmful. The immune system produces immunoglobulin E (IgE) antibodies, which normally help the body fight parasites. In the most severe cases individuals can suffer life-threatening reactions, including anaphylactic shock.

In previous research, Dr Nicoletti found that special types of white blood cells called dendritic cells are important in helping the immune system decide on how to respond to foreign molecules. In the latest research, Dr Nicoletti compared the activity of dendritic cells in the gut and in the spleen of allergic and allergy resistant mice. He found that in the gut of susceptible mice, dendritic cells have stopped producing IL-12.

This research was carried out in collaboration with the University of Siena.

“We have identified a molecule that is very important for the regulation of immune response and for the first time clearly represents a potential target for the therapy of allergy. This is currently under investigation”, said Dr Nicoletti.

David Reading, director of the Anaphylaxis Campaign, said: “Food allergy can place an extremely heavy burden on the families affected. We welcome this research and look forward to further developments.”

###

Contacts

Zoe Dunford, Media Manager
Institute of Food Research
t: 01603-255111
m: 07768-164185
e: zoe.dunford@bbsrc.ac.uk

Andy Chapple, Press Office Assistant
Institute of Food Research
t: 01603-251490
m: 07785-766779
e: andrew.chapple@bbsrc.ac.uk

Notes to editors

  • “Production of IL-12 by Peyer’s patch-dendritic cells is critical for the resistance to food allergy” will be published online by the Journal of Allergy and Clinical Immunology on Monday 2nd July 2007

  • The mission of the Institute of Food Research (www.ifr.ac.uk) is to undertake international quality scientific research relevant to food and human health and to work in partnership with others to provide underpinning science for consumers, policy makers, the food industry and academia. It is a company limited by guarantee, with charitable status, grant aided by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk).

  • The research was supported by a grant from the Biotechnology and Biological Sciences Research Council and intramural funds of the University of Siena.

  • The Biotechnology and Biological Sciences Research Council (BBSRC) is the UK funding agency for research in the life sciences. Sponsored by Government, BBSRC annually invests around £370 million in a wide range of research that makes a significant contribution to the quality of life for UK citizens and supports a number of important industrial stakeholders including the agriculture, food, chemical, healthcare and pharmaceutical sectors. www.bbsrc.ac.uk


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.